Interface, Inc. (TILE) Q4 2025 Earnings Call Summary

1Key Financial Results and Metrics

Q4 Net Sales: $349.4 million, up 4.3% as reported and 1.6% on a currency-neutral basis.

Full Year Net Sales: $1.39 billion, up 5.4% and at the high end of expectations; currency-neutral net sales increased 4.3%.

Adjusted Gross Profit Margin: Q4 at 38.6%, up 169 basis points; full year at 39%, up 187 basis points (excluding a nonrecurring inventory reserve adjustment, the margin would be approximately 38.5%).

Adjusted Operating Income: Q4 at $38.2 million, up 16.7%; full year at $173.8 million, up 22.9%.

Adjusted EBITDA: Q4 at $49.8 million, up 8.2%; full year at $217.9 million, up 15.3%.

Adjusted EPS: Q4 at $0.49, up 44.1%; full year at $1.94, a 33% increase.

2Strategic Updates and Business Highlights

One Interface Strategy: Continued success with the combined U.S. selling team model, leading to strong growth in health care (21% increase) and education (8% increase) segments.

Product Innovation: Launch of Noravant, a PVC-free rubber flooring product aimed at expanding market share in health care and education, expected to contribute $5-10 million in revenue in 2026.

Operational Efficiency: Investments in automation and robotics have improved productivity and reduced waste, with plans to extend these solutions globally.

Sustainability Focus: Continued commitment to sustainability with new low-carbon products and recognition in sustainability rankings.

3Forward Guidance and Outlook

Q1 2026 Guidance: Anticipated net sales of $315-325 million, adjusted gross profit margin around 38%, and adjusted SG&A expenses of approximately $94 million.

Full Year 2026 Guidance: Expected net sales of $1.42-1.46 billion, adjusted gross profit margin of 38.5-39%, and capital expenditures of approximately $55 million.

4Bad News, Challenges, or Points of Concern

Corporate Office Segment: Growth was flat, indicating challenges in this market compared to strong performance in health care and education.

Input Costs: Higher input costs are a concern, with tariff-related headwinds expected to impact gross margins by approximately 50 basis points in 2026.

Macro Environment: Ongoing uncertainties in the macroeconomic landscape and competitive pressures in the corporate market could pose risks to growth.

5Notable Q&A Insights

One Interface Strategy: Management highlighted the continued rollout of the One Interface strategy, emphasizing the scalability of the combined selling teams and the potential for further growth in health care and education.

Gross Margin Expectations: Management expressed confidence in maintaining and improving gross margins despite input cost pressures, attributing improvements to automation and operational efficiencies.

Backlog and Orders: A 7% increase in backlog year-to-date was noted, providing confidence for 2026 despite a competitive environment.

Focus on Innovation: There is a strong inclination to invest in new product development, with Noravant seen as a significant growth platform, expected to generate substantial revenue over the next five years. Overall, Interface, Inc. reported a strong performance in 2025, driven by strategic initiatives and operational efficiencies, while also navigating challenges in certain market segments and input costs. The outlook for 2026 remains positive, with continued focus on innovation and market expansion.